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ABSTRACT
Hydroxyapatite, chitosan, and carbon nanotube composite biomaterial were developed to improve bone healing. Previous 
studies suggested that a combination of biomaterials and mesenchymal stem cells (MSCs) can potentially help promote 
bone regeneration. In the present study, we first developed hydroxyapatite, chitosan, and carbon nanotube composite 
biomaterial. Then, the effect of different concentrations of the extract on the viability of Vero cells (ATCC CCL-81) and 
MSCs obtained from sheep bone marrow using methylthiazol tetrazolium (MTT) and propidium iodide (PI) assays 
were evaluated. The biomaterial group demonstrated an absence of cytotoxicity, similar to the control group. Samples 
with 50% and 10% biomaterial extract concentrations showed higher cell viability compared to samples from the control 
group (MTT assay). These results suggest that the presence of this composite biomaterial can be used with MSCs. This 
study also concluded that hydroxyapatite, chitosan, and carbon nanotube composite biomaterial were not cytotoxic. 
Therefore, these could be used for performing in vivo tests.
Keywords: Bone regeneration. Propidium iodide assay. Methylthiazol tetrazolium assay. Mesenchymal stem cells. 
Cytotoxicity.
RESUMO
O compósito à base de hidroxiapatita, quitosana e nanotubo de carbono foi desenvolvido com o intuito de auxiliar na 
consolidação óssea. Estudos anteriores sugerem que a combinação de substitutos ósseos e células-tronco mesenquimais 
(CTM) podem auxiliar a potencializar e promover a regeneração óssea. No presente estudo, o biomaterial foi desenvolvido 
e a viabilidade e a citotoxicidade de células Vero (ATCC CCL-81) e CTM obtidas de medula óssea provenientes de ovinos 
utilizando ensaios metil-tiazol-tetrazólio, MTT e iodeto de propídeo (PI) foram avaliadas em diferentes concentrações 
de extrato desse compósito. O compósito demonstrou ausência de citotoxicidade com comportamento semelhante ao 
grupo controle. Amostras com 50% e 10% de concentração de extrato do compósito mostraram resultados maiores 
comparados ao grupo controle (ensaio MTT). Esses resultados também sugerem que a presença do biomaterial pode ser 
utilizada em associação a CTM. Assim, esse estudo conclui que o compósito apresentado de hidroxiapatita, quitosana 
e nanotubo de cabono não foi considerado citotóxico e pode ser utilizado em teste in vivo.
Palavras-chave: Regeneração óssea. Iodeto de propídeo. Metil-tiazol-tetrazólio. Célula-tronco mesenquimal. 
Citotoxicidade.
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Numerous synthetic and biologically derived 
materials have been evaluated for use in the preservation 
or augmentation of bone defects (Emara  et  al., 2013). 
Several studies investigated biomaterials for use in bone 
tissue engineering by employing different methodologies 
(Marcondes et al., 2016; Milori et al., 2013; Nóbrega, 2014; 
Paretsis et al., 2017).
Hydroxyapatite (HA) is a well-known biomaterial 
component that is widely used because of its similarity 
to bone tissue, biocompatibility, and osteoconductivity 
(Azevedo et al., 2013; Dantas et al., 2011; Ferreira et al., 
2017; Notodihardjo et al., 2012; Reis et al., 2010). Chitosan 
is an easily processed biopolymer, known for its excellent 
biocompatibility, as well as antioxidant and antimicrobial 
properties (Spin-Neto  et  al., 2012; Tavakol  et  al., 2013; 
Tavaria et al., 2013; Tsuchiya et al., 2014). Carbon nanotubes 
have been used with both of these biomaterials to improve 
mechanical resistance and assist with bone osteoconduction 
(Barrientos-Durán et al., 2014; Shin et al., 2011).
A composite of HA, carbon nanotubes and chitosan has 
been previously prepared, although different raw material 
sources and procedures were used. Since these biomaterials 
have a uniform distribution and biocompatibility, they are 
considered potentially promising for applications in bone 
tissue engineering (Chen et al., 2013; Venkatesan et al., 2011).
Mesenchymal stem cells (MSCs) are multipotent cells 
capable of differentiating into different types of tissues 
and can be used to support tissue regeneration. MSCs are 
precursors of bone, cartilage, muscle, and fat cell lineages 
(Freitas et al., 2017; Portinho et al., 2006). The therapeutic 
use of MSCs is still highly promising for bone regeneration. 
More studies have been conducted on the utilization of 
MSCs and bone graft substitutes in combination, with an 
effort to engineer an optimal microenvironment for the 
regeneration and repair of damaged bone tissue (Lee et al., 
2019).
In vitro experiments allow us to simulate and predict 
biological reactions to implanted materials. Therefore, they 
should be performed first before in vivo biocompatibility 
tests. These in vitro tests enable the assessment of biomaterial 
cytotoxicity and reduce the need for animal models 
(Fidalgo et al., 2009; Masson et al., 2014; Schönberger et al., 
2007). Biomaterials interacting with host cells and/or tissues 
can cause numerous biological responses, such as altered 
cell morphology, metabolic activity, and behavior, affecting 
the potential clinical applications of these biomaterials 
(Masson et al., 2014).
In the present study, we evaluated the effect of HA, 
chitosan, and carbon nanotube composite scaffolds on the 
cytotoxicity and viability of Vero cells (ATCC CCL-81) and 
MSCs obtained from sheep bone marrow in vitro using 
methylthiazol tetrazolium (MTT) and propidium iodide 
(PI) assays.
This preclinical test aimed to determine if this biomaterial 
has any grade of cytotoxicity. We hypothesized that there is 
no high level of toxicity in different concentrations of the 
composite biomaterial for Vero cells and MSCs.
Materials and methods
The experimental design was proposed to describe the 
production and characterization of a biomaterial composite 
scaffold. MSCs were collected and differentiated to confirm 
the quality of the biomaterial used as a scaffold. MSC 
cultures with the biomaterials were performed to evaluate 
the biocompatibility of the biomaterial concerning the 
growth of MSCs. Cell viability was assessed by MTT and PI 
assays using the Vero cell line (ATCC CCL-81) and MSCs 
derived from sheep bone marrow, which was performed 
in triplicate. Vero cells were chosen as the first approach 
based on the study by Amaral et al. (2020) because they 
are easy to obtain and manipulate.
Preparation of biomaterial composite scaffold
Hydroxyapatite was synthesized from calcium nitrate and 
ammonium phosphate as previously described (Jarcho et al., 
1976). X-ray diffraction, performed using an X-ray 
diffractometer (Bruker D8 Advance Instrument, Karlsruhe, 
Germany), showed that the diffraction peaks matched 
those of the HA standard [HA, JCPDS 9-0432]. Energy-
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dispersive X-ray analysis, performed using an EDX LINK 
ANALYTICAL system (Isis System Series 200, Cambridge, 
England) coupled to an electronic microscope LEO 440 
(LEO Electron Microscopy Ltd, Cambridge, England), 
Oxford detector (Oxford Instruments Inc., Cambridge, 
England), demonstrated a calcium/phosphorus (Ca/P) ratio 
of 1.89, consistent with a calcium-rich HA (Ramesh et al., 
2007). Chitosan was obtained by deproteinization and 
demineralization of squid gladius (Doryteuthis spp.). The 
molecular weight (MW) and degree of deacetylation (DD) 
were determined by viscosimetric and 1H NMR spectroscopy, 
respectively. The DD value was 93.5% (Horn et al., 2009) 
and the MW was 2.83 ± 0.6×105 Da. Carbon nanotubes 
(CNTs) were multi-walled, had a 9.5 nm diameter and 
1.5 μm length, and were functionalized with carboxylic 
acid (>8%) (Aldrich, Saint Louis, USA). To prepare the 
scaffold, CNTs were suspended in 1% acetic acid. Chitosan 
was then slowly added and stirred at 2000 rpm for 24 h 
to achieve complete dissolution. The same procedure was 
performed in adding HA. The final ratio of the biomaterials 
was 1:20:180 (carbon nanotubes:chitosan:HA).
To prepare the scaffolds, 100 mg and 500 mg of the 
solution were placed into Teflon® molds with dimensions 
of 70 mm diameter × 2 mm height and 100 mm diameter 
× 2 mm height, respectively, frozen in liquid nitrogen, and 
lyophilized in an Edwards model Freeze Dryer Modulyo 
(Edwards High Vacuum International, West Sussex, UK). 
Matrices were neutralized in a 0.1 mol/L NaHCO3 solution 
followed by multiple washes with deionized water and 
subsequent freezing and lyophilization (Figure 1).
Characterization of scaffolds
Morphological evaluation of the scaffold was performed 
using scanning electron microscopy (SEM). The sample was 
mounted on aluminum stubs with carbon tape, sputter-coated 
with Au/Pd using a Coating System BAL-TEC MED 020 
(BAL-TEC, Liechtenstein) under 2.00 × 10-2 mbar pressure, 
60 mA current, and 0.60 nm s-1 deposition rate. ZEISS 
LEO 440 (Cambridge, England) equipment and OXFORD 
(model 7060) detector, operated at a voltage of 20 keV, were 
used. Images were acquired using a quadrant backscattered 
electron detector (QBSD) type 400 at 2.82 A current and 
with an I 1500 nA probe.
Isolation of mesenchymal stem cells from sheep 
bone marrow
Aspiration of the iliac crest bone marrow obtained 
from a two-month-old Dorper sheep was performed to 
isolate MSCs.
Bone marrow was collected in 20 mL vials coated with 
sodium heparin. Immediately, the blood was diluted with 
phosphate-buffered saline (PBS) and layered over in Ficoll 
Histopaque®-1077 (1.077 g/mL) in a 1:1 ratio. The mononuclear 
fraction was harvested after density gradient centrifugation 
for 30 min at 1400 × g. The mononuclear cells were rinsed 
in the same volume of PBS and then centrifuged for 10 min 
at 2000 × g. Subsequently, the samples were rinsed again 
using the same conditions.
The cell pellets were suspended and then plated in a 
basal medium consisting of 5 mL Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal 
bovine serum, 1% penicillin/streptomycin, 1% pyruvic 
acid, 1% L-glutamine, 1% insulin, and 0.5% B-amphotericin 
(LGC, Biotechnology, Brazil). The cells were cultured in 
control media until 80% confluence at 37 °C and 5% CO2 
in a humidified incubator. Next, the cells were trypsinized 
and frozen at -80 °C for 24 h and then at -196 °C in liquid 
nitrogen.
To verify the multipotentiality of MSCs, the cells 
were differentiated into osteoblasts, adipocytes, and 
chondrocytes according to standard protocols (Burk et al., 
2017; Fülber et al., 2016).
Figure 1 - Hydroxyapatite, chitosan, and carbon nanotube disk biomaterial composite (70 mm diameter x 2 mm height) (A) and 
100 mm diameter x 2 mm height (B).
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Mesenchymal cell culture with biomaterials
The analysis of the biocompatibility of the biomaterials, 
concerning the growth of MSCs, was performed using two 
protocols to confirm if the biomaterial had any inert or 
harmful characteristics after their interaction. The MSCs 
were placed directly on top of the biomaterials in culture 
flasks (2D). Then, the MSCs were cultured until 70-80% 
confluence (about eight days). The second protocol was 
carried out using MSCs already attached to the culture 
flasks. For this, the biomaterial was added to the flask and 
allowed to maintain contact with the cells in culture until 
a confluence of 70-80% was attained.
Effect of the biomaterial on cell viability (MTT assay)
The viability of cultured cells was determined using the 
colorimetric MTT assay according to the manufacturer’s 
protocol (Amaral et al., 2020). Two types of cells were used 
for this assay, the Vero cell line (ATCC CCL-81) and MSCs.
The cells were seeded onto 96-well plates at a density 
of 1×105 cells/mL and incubated under standard culture 
conditions. Extracts from the biomaterials were obtained 
according to ISO 10993-12 standards. Extracts from the 
composite biomaterial were prepared by incubating the 
pre-sterilized biomaterial (7 mm × 1 mm size) in 2 mL of 
the DMEM media for 24 h at 37 °C. The extract solution 
was prepared at different concentrations in the media 
previously described (Duarte, 2015).
Cells were incubated with different concentrations of 
the extract (100%, 90%, 75%, 60%, 50%, 25%, and 10%) 
for 48 h. Latex at concentrations of 100% and 50% were 
subjected to the same conditions and used as a positive 
control. Undiluted culture media in DMEM was used as a 
negative control. At the end of the incubation period, the 
culture medium was replaced with fresh media containing 
3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium 
bromide (MTT) solution.
The media was removed after 2 h and the reaction was 
terminated by the addition of 100 μL dimethyl sulfoxide 
(DMSO) to each well as a solubilization buffer to dissolve 
the formazan crystals. The lysate absorbance was then 
measured using a microplate reader (ELISA BIO-RAD) 
at 500 nm.
Propidium iodide (PI assay)
The Vero cell line and the MSCs were cultured and 
incubated as previously described, and then stained with 
PI. After 15 min of incubation at 37° C, the cells were 
immediately observed using an inverted fluorescence 
microscope (Carl Zeiss, Inc, Germany).
Statistical analysis
The results were expressed as the triplicate means ± 
standard deviation and analyzed using GraphPad Prism 
software Version 6. Statistical analysis was performed 
using one-way ANOVA, and differences were considered 
significant at *p < 0.05.
Results
Characterization of the scaffold
SEM images (Figure 2) of the scaffold surface show a 
compact composite with distributed materials.
Isolation of mesenchymal stem cells
The isolated MSCs from bone marrow cultures 
demonstrated growth, proliferation, and adhesion in seven 
Figure 2 - SEM photomicrograph of the scaffold. (A) 1000× magnification, scattering detector, and (B) 3000× magnification, 
quadrant backscattered electron detector.
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days. MSCs had a fibroblastic morphology and grew as a 
monolayer. After 15 days, the cell cultures reached ~70% 
confluence (Figure 3A).
Mesenchymal stem cell culture with biomaterials
Mesenchymal stem cells cultured with biomaterials 
since the beginning of the experiments were able to adhere 
and grow according to the first protocol. Adhesion and 
growth on the MSC culture with biomaterials were also 
observed (Figure 3B).
For the second protocol, where the biomaterial was 
introduced after the MSCs were confluent, similar results 
were observed. No cell death was detected.
MTT assay
Figure 4A presents the MTT results for Vero cells in 
P3. There was no difference in cell viability between the 
control group (blank) and the different biomaterial extract 
concentrations. The groups with 50% and 10% concentrations 
showed higher cell viability than the control group. None 
Figure 3 - Representative images of MSCs obtained from sheep bone marrow during cell culture (P3) showing ≥ 100% confluence 
in the region. MSC cultures observed using an inverted microscope at 10× magnification (A); MSCs on biomaterials as 
observed using an inverted microscope at 4× magnification (first protocol) (B).
Figure 4 - MTT absorbance with Vero cells (A); MTT absorbance with MSCs (B); Dead cell count with Vero (PI assay) (C); Dead 
cell count with MSCs (PI assay) (D).
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of the groups presented absorbances similar to the positive 
control (latex).
Figure 4B shows the MTT assay results for the MSCs 
at P3. There was an increase in viable cells in the presence 
of biomaterial scaffolds at different concentrations, with 
the absorbances in groups with 100%, 75%, and 25% 
concentrations higher than the control group.
PI assay
As expected, the PI assay in Vero cells demonstrated 
the presence of dead cells in the positive control group. 
The samples from the negative control group (blank), as 
well as the samples containing various concentrations of 
the biomaterial extract, showed a similar number of dead 
cells (Figure 4C).
Meanwhile, the PI assay performed with the MSCs 
showed that the number of dead cells in the biomaterial-
containing samples was higher than that in the negative 
control group (blank). However, the number of dead cells 
in the biomaterial-containing samples was lower than that 
in the positive control group (latex) (Figure 4D).
Discussion
Although materials such as HA, chitosan, and carbon 
nanotubes are well known, only a few studies have 
examined the composite biomaterial containing all 
three materials (Chen et al., 2013; Türk et al., 2018). To 
develop this type of biomaterial, natural raw materials 
were used to extract chitosan, and HA was synthesized 
in the laboratory. The only commercial material was 
carbon nanotubes, which were included to improve 
material resistance.
In this study, HA, chitosan, and carbon nanotube 
composite biomaterial were evaluated in vitro for their 
effects on cell viability and cytotoxicity. The MTT and PI 
assays demonstrated the absence of cytotoxic effects in all 
tested cells.
The MTT assay measures the reduction of the tetrazolium 
component MTT by viable cells (Patel et al., 2009; Türk et al., 
2018). Therefore, the level of reduction reflects the level 
of cell metabolism, quantifying mitochondrial activity 
(Gupta et al., 2017). The MTT assay demonstrated that cells 
cultured with different concentrations of the biomaterial 
extract had similar levels of metabolic activity compared 
to the control.
Our results corroborate the findings of Masson et al. 
(2014). Their group used the MTT assay to test the viability 
of NCTC Clone 929 (ATCC/CCL-1) and Vero (ATCC/
CCL-81) cells on different biomaterials (samples of Bioglass® 
45S5 and glass-ceramics from the 3CaO.P2O5-SiO2-MgO 
system). The authors considered the biomaterials to be 
non-cytotoxic and emphasized the good quantitative 
characteristics of this assay. Previously, similar MTT results 
were obtained for other bone regeneration biomaterials, and 
no distinction was observed between the negative control 
and the biomaterial extract samples (Ahmad et al., 2017; 
Sun et al., 2018).
In the present study, the MTT assays showed that Vero 
cells at 50% and 10% concentrations of biomaterial extract 
had higher absorbance compared to those of the control 
group. MSCs also had higher absorbance levels than the 
control group at 100% and 75% – 25% concentrations of the 
biomaterial extract. These results suggest that biomaterial 
presence can be considered a favorable environment for cells. 
Similar conclusions were also reached in a cytotoxicity study 
performed with HuGu cells (human gum fibroblasts) by MTT 
assay for 72 h. These results showed higher cell proliferation 
and absence of cytotoxicity (Abd-Khorsand et al., 2017).
In the cytotoxicity assay, PI can only interact with 
nuclear DNA from cells with disrupted cytoplasmic and 
nuclear membranes, staining the nuclei red (Pan  et  al., 
2012). The cytotoxicity of the different concentrations of 
the biomaterial extract in cultured MSCs was lower than 
that of the positive control group. It could be that MSCs 
were more sensitive to the presence of the biomaterial 
extract. However, this biomaterial cannot be considered 
significantly cytotoxic because the cell death in the positive 
control (latex) was significantly higher than the different 
concentrations of the biomaterial extract. For these reasons, 
several cytotoxicity methods are recommended to be used 
to provide complete information about the material under 
investigation (Jorge et al., 2004).
In the present study, Vero cells demonstrated similar 
results to MSCs as determined by MTT and PI assays. 
Nevertheless, other studies evaluated the effects of different 
bone-grafting materials on MSC culture using MTT and 
PI assays to conclude that their respective biomaterials 
presented a favorable microenvironment that improved 
adhesion, proliferation, and differentiation of the studied 
cells (Gupta et al., 2017; Pan et al., 2012).
It was not possible to use osteogenic cells in this study 
and there was no positive control in the MSC cultures with 
unknown objects. This could be considered a study limitation, 
although the composite biomaterial demonstrated in this 
preclinical study showed pertinent results.
In vitro and in vivo studies are excellent tools to evaluate 
the potential of the combination of the biomaterial and 
MSCs to improve biomaterial osseointegration and increase 
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tissue neoformation, with a quantity and quality equal 
to or better than the control group (Freitas et al., 2017; 
Portinho et al., 2006).
Comparing these results with those of previous studies 
(Ahmad et al., 2017; Masson et al., 2014; Sun et al., 2018), HA, 
chitosan, and carbon nanotube composite biomaterial was not 
considered cytotoxic. This composite biomaterial appears to 
provide a favorable environment for use in association with 
sheep-derived MSCs to assist tissue regeneration. However, 
more in vitro and in vivo studies are needed to confirm the 
use of this biomaterial as a bone substitute.
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